{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:37:30Z","timestamp":1768523850024,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000016","name":"Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jsat.2021.108395","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T20:48:49Z","timestamp":1617914929000},"page":"108395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The Integrating Medications for Addiction Treatment (IMAT) Index: A measure of capability at the organizational level"],"prefix":"10.1016","volume":"126","author":[{"given":"Helene","family":"Chokron Garneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meaghan","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Caton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsat.2021.108395_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10488-010-0327-7","article-title":"Advancing a conceptual model of evidence-based practice implementation in public service sectors","volume":"38","author":"Aarons","year":"2011","journal-title":"Administration and Policy in Mental Health and Mental Health Services Research"},{"key":"10.1016\/j.jsat.2021.108395_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13311-019-00814-4","article-title":"Availability of medications for the treatment of alcohol and opioid use disorder in the USA","volume":"17","author":"Abraham","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.jsat.2021.108395_bb0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/s12913-019-4624-x","article-title":"Implementing integrated services in routine behavioral health care: Primary outcomes from a cluster randomized controlled trial","volume":"19","author":"Assefa","year":"2019","journal-title":"BMC Health Services Research"},{"issue":"8","key":"10.1016\/j.jsat.2021.108395_bb0025","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/add.13364","article-title":"Estimating demand for primary care-based treatment for substance and alcohol use disorders","volume":"111","author":"Barry","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108395_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15504263.2013.779051","article-title":"Measuring organizational capacity for integrated treatment","volume":"9","author":"Bond","year":"2013","journal-title":"Journal of Dual Diagnosis"},{"issue":"1","key":"10.1016\/j.jsat.2021.108395_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11414-014-9419-6","article-title":"The impact of technical assistance and implementation support on program capacity to deliver integrated services","volume":"43","author":"Chaple","year":"2016","journal-title":"The Journal of Behavioral Health Services & Research"},{"key":"10.1016\/j.jsat.2021.108395_bb0040","series-title":"Medication-assisted treatment models of care for opioid use disorder in primary care settings","author":"Chou","year":"2016"},{"issue":"6 PART1","key":"10.1016\/j.jsat.2021.108395_bb0045","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/1475-6773.12111","article-title":"Assessing progress toward becoming a patient-centered medical home: An assessment tool for practice transformation","volume":"48","author":"Daniel","year":"2013","journal-title":"Health Services Research"},{"issue":"1","key":"10.1016\/j.jsat.2021.108395_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-018-3241-4","article-title":"Using NIATx strategies to implement integrated services in routine care: A study protocol","volume":"18","author":"Ford","year":"2018","journal-title":"BMC Health Services Research"},{"issue":"1","key":"10.1016\/j.jsat.2021.108395_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08897077.2015.1088496","article-title":"Optimizing psychosocial support during office-based buprenorphine treatment in primary care: Patients\u2019 experiences and preferences","volume":"37","author":"Fox","year":"2016","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2021.108395_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3122\/jabfm.19.1.11","article-title":"RE-AIMing research for application: Ways to improve evidence for family medicine","volume":"19","author":"Glasgow","year":"2006","journal-title":"Journal of the American Board of Family Medicine"},{"key":"10.1016\/j.jsat.2021.108395_bb0065","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: The RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.jsat.2021.108395_bb0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11414-012-9317-8","article-title":"Assessing the co-occurring capability of mental health treatment programs: The dual diagnosis capability in mental health treatment (DDCMHT) index","volume":"40","author":"Gotham","year":"2013","journal-title":"Journal of Behavioral Health Services and Research"},{"issue":"2","key":"10.1016\/j.jsat.2021.108395_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jsat.2009.07.005","article-title":"Increasing program capability to provide treatment for co-occurring substance use and mental disorders: Organizational characteristics","volume":"38","author":"Gotham","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.jsat.2021.108395_bb0080","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/add.12117","article-title":"Which elements of improvement collaboratives are most effective? A cluster-randomized trial","volume":"108","author":"Gustafson","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108395_bb0085","series-title":"SUMMIT: Procedures for medication-assisted treatment of alcohol or opioid dependence in primary care","author":"Heinzerling","year":"2017"},{"key":"10.1016\/j.jsat.2021.108395_bb0090","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1186\/s12913-019-4751-4","article-title":"Opioid use disorder and treatment: Challenges and opportunities","volume":"19","author":"Hoffman","year":"2019","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.jsat.2021.108395_bb0100","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.drugalcdep.2016.08.642","article-title":"Buprenorphine physician supply: Relationship with state-level prescription opioid mortality","volume":"173","author":"Knudsen","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108395_bb0105","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care-based models for the treatment of opioid use disorder: A scoping review","volume":"166","author":"Korthuis","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108395_bb0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","article-title":"Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of the Massachusetts collaborative care model in community health centers","volume":"60","author":"LaBelle","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2021.108395_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/ADM.0b013e318276e7a4","article-title":"Organizational capacity to address co-occurring substance use and psychiatric disorders: Assessing variation by level of care","volume":"7","author":"Lambert-Harris","year":"2013","journal-title":"Journal of Addiction Medicine"},{"issue":"6","key":"10.1016\/j.jsat.2021.108395_bb0120","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1465-3362.2009.00116.x","article-title":"Differences in self and independent ratings on an organisational dual diagnosis capacity measure","volume":"28","author":"Lee","year":"2009","journal-title":"Drug and Alcohol Review"},{"issue":"9","key":"10.1016\/j.jsat.2021.108395_bb0125","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/M18-1652","article-title":"The next stage of buprenorphine care for opioid use disorder","volume":"169","author":"Martin","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108395_bb0130","series-title":"Integrating Medications for Addiction Treatment in Primary Care \u2013 Opioid Use Disorder Version 1.3: An index of capability at the organizational\/clinic level","author":"McGovern","year":"2019"},{"issue":"2","key":"10.1016\/j.jsat.2021.108395_bb0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10488-012-0449-1","article-title":"Dual diagnosis capability in mental health and addiction treatment services: An assessment of programs across multiple state systems","volume":"41","author":"McGovern","year":"2014","journal-title":"Administration and Policy in Mental Health and Mental Health Services Research"},{"issue":"3\u20134","key":"10.1016\/j.jsat.2021.108395_bb0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/15504263.2010.537221","article-title":"Improving the dual diagnosis capability of addiction and mental health treatment services: Implementation factors associated with program level changes","volume":"6","author":"McGovern","year":"2010","journal-title":"Journal of Dual Diagnosis"},{"issue":"2","key":"10.1016\/j.jsat.2021.108395_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1300\/J374v03n02_13","article-title":"Assessing the dual diagnosis capability of addiction treatment services: The dual diagnosis capability in addiction treatment (DDCAT) index","volume":"3","author":"McGovern","year":"2007","journal-title":"Journal of Dual Diagnosis"},{"issue":"4","key":"10.1016\/j.jsat.2021.108395_bb0150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jsat.2012.08.013","article-title":"Development and initial feasibility of an organizational measure of behavioral health integration in medical care settings","volume":"43","author":"McGovern","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"04\u20133939","key":"10.1016\/j.jsat.2021.108395_bb0155","first-page":"1","article-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction","volume":"40","author":"McNicholas","year":"2004","journal-title":"Treatment Improvement Protocol"},{"key":"10.1016\/j.jsat.2021.108395_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsat.2019.07.013","article-title":"Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact","volume":"108","author":"Miele","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108395_bb0165","series-title":"The ASAM principles of addiction medicine","author":"Miller","year":"2019"},{"issue":"1","key":"10.1016\/j.jsat.2021.108395_bb0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","article-title":"Medication treatment for opioid use disorders in substance use treatment facilities","volume":"38","author":"Mojtabai","year":"2019","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2021.108395_bb0175","series-title":"Medications for opioid use disorder save lives","article-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, Engineering, and M. H. and M. D. B. on H. S. P. C. on M.-A. T. for O. U. D","year":"2019"},{"issue":"2","key":"10.1016\/j.jsat.2021.108395_bb0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/ADM.0000000000000200","article-title":"Using a learning collaborative strategy with office-based practices to increase access and improve quality of care for patients with opioid use disorders","volume":"10","author":"Nordstrom","year":"2016","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2021.108395_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2018.12.006","article-title":"Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey","volume":"98","author":"Novak","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108395_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2018.04.004","article-title":"Patient predictors of substance use disorder treatment initiation in primary care","volume":"90","author":"Ober","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108395_bb0195","article-title":"Facilitators and barriers to utilization of medications for opioid use disorder in primary care in South Carolina","author":"Oros","year":"2020","journal-title":"International Journal of Psychiatry in Medicine"},{"issue":"11","key":"10.1016\/j.jsat.2021.108395_bb0200","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/01.mlr.0000233683.82254.63","article-title":"A fidelity measure for integrated management of depression in primary care","volume":"44","author":"Oxman","year":"2006","journal-title":"Medical Care"},{"issue":"2","key":"10.1016\/j.jsat.2021.108395_bb0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/15504263.2013.778441","article-title":"Dual diagnosis capability in mental health and substance use disorder treatment programs","volume":"9","author":"Padwa","year":"2013","journal-title":"Journal of Dual Diagnosis"},{"issue":"10","key":"10.1016\/j.jsat.2021.108395_bb2005","first-page":"20","article-title":"Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders","volume":"97","author":"Park","year":"2014","journal-title":"Rhode Island Medical Journal"},{"issue":"2","key":"10.1016\/j.jsat.2021.108395_bb2010","first-page":"109","article-title":"Patient and provider comfort discussing substance use","volume":"45","author":"Ray","year":"2013","journal-title":"Family Medicine"},{"issue":"5","key":"10.1016\/j.jsat.2021.108395_bb0210","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jsat.2012.11.001","article-title":"Improving the capability to provide integrated mental health and substance abuse services in a state system of outpatient care","volume":"44","author":"Sacks","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108395_bb0215","series-title":"The patient-centered medical home assessment version 4.0","author":"Safety Net Medical Home Initiative","year":"2014"},{"key":"10.1016\/j.jsat.2021.108395_bb0220","series-title":"Integrated treatment for co-occurring disorders: The evidence. DHHS Pub. No. SMA-08-4366","author":"Substance Abuse and Mental Health Services Administration","year":"2009"},{"key":"10.1016\/j.jsat.2021.108395_bb0225","series-title":"DDCAT dual diagnosis capability in addiction treatment (DDCAT) toolkit dual diagnosis capability in addiction treatment toolkit acknowledgements","author":"Substance Abuse and Mental Health Services Administration","year":"2011"},{"key":"10.1016\/j.jsat.2021.108395_bb0230","series-title":"DDCMHT dual diagnosis capability in mental health treatment (DDCMHT) toolkit","author":"Substance Abuse and Mental Health Services Administration","year":"2011"},{"key":"10.1016\/j.jsat.2021.108395_bb0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","article-title":"Making sense of Cronbach\u2019s alpha","volume":"2","author":"Tavakol","year":"2011","journal-title":"International Journal of Medical Education"},{"issue":"4","key":"10.1016\/j.jsat.2021.108395_bb0240","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1353\/cpr.2017.0047","article-title":"Implementing the chronic care model for opioid and alcohol use disorders in primary care","volume":"11","author":"Watkins","year":"2017","journal-title":"Progress in Community Health Partnerships: Research, Education, and Action"},{"key":"10.1016\/j.jsat.2021.108395_bb0245","first-page":"13","article-title":"To Battle the opioid overdose epidemic, deploy the \u201ccascade of care\u201d model","author":"Williams","year":"2017","journal-title":"Health Affairs Blog"},{"issue":"1","key":"10.1016\/j.jsat.2021.108395_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a cascade of care for responding to the opioid epidemic","volume":"45","author":"Williams","year":"2019","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2021.108395_bb0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2018.06.001","article-title":"Developing an opioid use disorder treatment cascade: A review of quality measures","volume":"91","author":"Williams","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2021.108395_bb0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","article-title":"Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder","volume":"177","author":"Williams","year":"2020","journal-title":"The American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jsat.2021.108395_bb0265","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1370\/afm.406","article-title":"The break-even point\u202f: When medical advances are less","volume":"3","author":"Woolf","year":"2005","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/j.jsat.2021.108395_bb0270","series-title":"The role of community health centers in addressing the opioid epidemic","author":"Zur","year":"2018"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:54:28Z","timestamp":1760039668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":54,"alternative-id":["S0740547221001215"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108395","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Integrating Medications for Addiction Treatment (IMAT) Index: A measure of capability at the organizational level","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108395"}}